Label-free quantitative proteomics (LFQ) of Giardia lamblia/intestinalis treated with Dasatinib

ABSTRACT: This study employed quantitative label-free proteomics to investigate the molecular effects of dasatinib, a repurposed drug, on Giardia lamblia, a protozoan parasite causing giardiasis. G. lamblia trophozoites were treated with 12.5 micromolar dasatinib, and protein expression changes were analyzed at 24, 30, 36, and 42 hours post-treatment.

INSTRUMENT(S): Orbitrap Exploris 480

ORGANISM(S): Giardia Intestinalis (ncbitaxon:5741)

SUBMITTER: Nurulhasanah Othman  

PROVIDER: MSV000097321 | MassIVE | Fri Mar 14 02:49:00 GMT 2025

REPOSITORIES: MassIVE